Search company, investor...
Vital Therapies company logo

Vital Therapies

Founded Year




Total Raised


Date of IPO


Market Cap


Stock Price


About Vital Therapies

Vital Therapies is a development-stage biotechnology company developing ELAD, an extracorporeal liver support system which functions by processing toxins and synthesizing proteins and metabolites that are the key processes of normal human liver function, and represents the first human allogeneic cellular therapy for life-threatening acute liver failure. Vital Therapies has completed seven clinical trials in US, EU and Asia. A US/EU pivotal trial plan to secure BLA and MAA approval has received written guidance from FDA and EMA. The first protocol under this plan, for a survival trial in acute alcoholic hepatitis, has been allowed by FDA and is open for enrollment.

Headquarters Location

15010 Avenue of Science Suite 200

San Diego, California, 92128,

United States


Missing: Vital Therapies's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Vital Therapies's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Vital Therapies Patents

Vital Therapies has filed 7 patents.

patents chart

Application Date

Grant Date


Related Topics




G protein coupled receptors, Human cell lines, Transcription factors, Complement system, Immunology


Application Date


Grant Date



Related Topics

G protein coupled receptors, Human cell lines, Transcription factors, Complement system, Immunology



Latest Vital Therapies News

Global Alcoholic Hepatiti Drug Market 2019 – Alfact Innovation, Generon (Shanghai) Corp Ltd, Gilead Sciences Inc, GRI Bio Inc

Apr 8, 2020

The Alcoholic Hepatiti Drug Market report contains wide-broadening verifiable evaluation for Alcoholic Hepatiti Drug, which empowers the client to isolate the future complicity and gauge right execution. The headway rate is assessed reliant on keen examination that gives the believable data on the overall Alcoholic Hepatiti Drug advertise. Goals and progression focuses are combined after a critical cognizance of the improvement of Alcoholic Hepatiti Drug advertise. The report is all around made by considering its basic data in the general Alcoholic Hepatiti Drug advertise, the basic parts responsible for the enthusiasm for its items and organizations. Our best examiners have overviewed the Alcoholic Hepatiti Drug advertise report with the reference of inventories and information given by the key players (Alfact Innovation, Generon (Shanghai) Corp Ltd, Gilead Sciences Inc, GRI Bio Inc, Immuron Ltd, Intercept Pharmaceuticals Inc, Promethera Biosciences SA, Verlyx Pharma Inc, Vital Therapies Inc), adaptable sources and records that assistance to update insight of the related methodological conditions. The Alcoholic Hepatiti Drug showcase report demonstrates a point by point division (F-652, GRI-0621, HepaStem, IMM-124E, Others) of the general market dependent on improvement, item type, application, and particular methods and frameworks. The point-to-point explanation of the Alcoholic Hepatiti Drug market’s gathering framework, the utilization of progression, finishes of the world market players, vendors and shippers’ organization, and the unequivocal business information and their improvement plans would help our clients for future approaches and development wanted to make due in the Alcoholic Hepatiti Drug showcase. The Alcoholic Hepatiti Drug showcase report incorporates the most recent mechanical improvements and new discharges to draw in our clients to the design, settle on showed business choices, and complete their required executions later on. The Alcoholic Hepatiti Drug advertise report additionally concentrates more on current business and present-day types of progress, future procedure changes, and open portals for the Alcoholic Hepatiti Drug showcase. Close-by movement systems and projections are one of the key portions that unmistakable up by and large execution and fuse key land examination (Hospital, Clinic, Others). Ask about the report here: The general Alcoholic Hepatiti Drug advertise is made with the key and direct end to misuse the Alcoholic Hepatiti Drug showcase and take part in business movement for basic business openings. The right figures and the graphical delineation of the Alcoholic Hepatiti Drug advertise are appeared in a spoke to technique. The report demonstrates an examination of possible dispute, current market plans and other fundamental attributes all around the globe. Research Objective :  Our board of exchange patrons besides as exchange experts over the value chain have taken huge endeavors in doing this gathering activity and hard work add request to create the key players with helpful essential and auxiliary information concerning the world Alcoholic Hepatiti Drug advertise. moreover, the report furthermore contains contributions from our exchange specialists that may encourage the key players in sparing their time from the inside investigation half. firms WHO get and utilize this report will be totally benefitted with the surmisings conveyed in it. but this, the report furthermore gives top to bottom investigation on Alcoholic Hepatiti Drug deal in addition in light of the fact that the components that impact the customers also as ventures towards this strategy. Much obliged for perusing this article; you’ll have the capacity to moreover get singular part astute segment or district savvy report adaptation like North America, Europe, Asia-Pacific, South America, geographic zone and landmass.

Vital Therapies Frequently Asked Questions (FAQ)

  • When was Vital Therapies founded?

    Vital Therapies was founded in 2003.

  • Where is Vital Therapies's headquarters?

    Vital Therapies's headquarters is located at 15010 Avenue of Science, San Diego.

  • What is Vital Therapies's latest funding round?

    Vital Therapies's latest funding round is IPO.

  • How much did Vital Therapies raise?

    Vital Therapies raised a total of $189.24M.

  • Who are the investors of Vital Therapies?

    Investors of Vital Therapies include Sears Capital Management, Satter Investment Mangement, Valley Ventures, Toucan Capital, MedVenture Associates and 15 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.